Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

The 2022 Tandem Meetings | Moving CAR-T therapy to the outpatient setting

Christopher Dandoy • 23 Apr 2022
The 2022 Tandem Meetings
General CAR-T

Christopher Dandoy, MD, MSc, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, discusses the key points from the ‘Quality in Cellular Therapy’ Session that took place at TCT. The experts discussed transitioning CAR-T therapy to the outpatient setting, as well as how the CAR-T therapy field is evolving. This interview took place at the Transplantation & Cellular Therapy (TCT) Meetings of ASTCT™ and CIBMTR® 2022 in Salt Lake City, Utah.

More from Christopher Dandoy

2:16
Cardiac complications after SCT
Christopher Dandoy • 23 Apr 2022
2:04
Sleep quality and weight loss in stem cell transplant recipients
Christopher Dandoy • 23 Apr 2022
1:44
Patient-important outcomes in pediatric transplant recipients
Christopher Dandoy • 23 Apr 2022
0:51
The importance of precision dosing in transplant recipients
Christopher Dandoy • 23 Apr 2022

Related Videos

4:07
Pooled fecal allogeneic microbiotherapy to treat refractory gastrointestinal acute GvHD
Florent Malard • 11 Apr 2024
5:23
Current and emerging treatment approaches for steroid-refractory acute & chronic GvHD
Mohamad Mohty • 17 Apr 2024
2:00
HHV-6 reactivation after haploidentical transplantation with PTCy & ATG: incidence and risk factors
Rémy Duléry • 15 Apr 2024
1:41
The consequences of regulatory changes on access to devices and reagents needed for graft processing
Christian Chabannon • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals